Gem Aromatics Limited

📍 Mumbai, Maharashtra, India Active NSE GEMAROMA CIN U24246MH1997PTC111057

Search companies

Key Metrics of Gem Aromatics Limited

Revenue₹371 CrFY 2025-26

EBITDA₹51.6 Cr

Net profit₹26.7 Cr

Net worth₹476 Cr

About Gem Aromatics Limited

Company details

Registered office: A/410 Kailash Complex Vikhroli Powai, Link Road, Park Site, Vikhroli (w)., Mumbai, 400079
Listed: NSE: GEMAROMA · ₹137.04

Company summary

Entity details

CINU24246MH1997PTC111057

LEI code335800ZZAE23XEGGOB31

State codeMH

PIN code400079

Current legal nameGEM AROMATICS LIMITED

Classification—

Listing statusListed (NSE: GEMAROMA)

Registration no.111057

Company age—

PAN—

CountryIndia

CityMumbai

StateMaharashtra

Current statusActive

Date of incorporation—

Registrar of companies—

Authorised capital—

Paid-up capital—

Employee count—

Compliance

Last AGM date—

Last balance sheet—

Next filing dueMGT-7 for FY 2025-26 · 29 Nov 2026

Industry classification

NIC code24246

Description of main activityManufacture of chemicals and chemical products (incl. pharmaceuticals)

Description of business activityManufacture of chemicals and chemical products (incl. pharmaceuticals)

SectorOther Industries · Discovered Companies

Premium

Financials, ratios and risk analysis

Revenue, EBITDA, net profit, net worth, debt and assets for every filing year, 15+ ratios, the financial health score, shareholding, charges and peer comparison are part of the premium plan.

Filing compliance

AGM for FY 2025-2630 Sep 2026 Statutory due date passed

AOC-4 for FY 2025-2630 Oct 2026 Statutory due date passed

MGT-7 for FY 2025-2629 Nov 2026 Statutory due date · 28 days left

Due dates follow the Companies Act: AGM within six months of the year end, AOC-4 within 30 days and MGT-7 within 60 days of the AGM. A filing made but not yet uploaded here shows as pending.

Vendor checks & payment capacity

Credit ratings

CARE · 04 Apr 2018 — Other

Change in last 12 monthsNo change

Change since first rating on record▲ 1 notchsince Aug 2014

Rating actions40 up · 0 down

Rating history

Rating actions

Date	Agency	Action	Long term	Short term	Outlook	Rated amount	Rationale
04 Apr 2018	CARE	Other	—	—	—	—	View
03 Feb 2017	CARE	Reaffirmed	BB	A4	Stable	₹31.9 Cr	View
20 Oct 2015	CARE	Other	—	—	—	—	View
27 Aug 2014	CARE	Assigned	BB-	A4	—	₹584 Cr	View

Borrowings & rated debt

Rated borrowing limits (latest)₹31.9 Cr

Peak rated limits₹584 CrAug 2014 · CARE

Limits raised0 times1 new facility rated

Rated limits over time

Facility mix

Rated facilities

Facility	Type	Previous	Current	Change	Rating	Action	Agency
Facilities Ratings Ration Action Long-term Bank Facilities	Working capital & bank lines	—	₹29.9 Cr	—	BB (Stable)	Reaffirmed	CARE
Short-term Bank Facilities [Reduced Rs.5.00 crore]	Working capital & bank lines	—	₹2.00 Cr	—	A4	Reaffirmed	CARE

Credit assessment · Manufacturing

Rating Methodology – Manufacturing Companies (Mar 2025) · Standalone accounts · FY 2025-26

Indicative long-term—

Indicative short-term—

Score—

LiquidityAdequate

DirectionStable

CARE rating · Apr 2018—

Ratios, pillar scores and the indicative rating are part of Premium.

Rating status

Default	No default on record
Issuer cooperation	Cooperating
Credit enhancement	None – standalone rating
Next action stable or better (model)	41%
Information on file	56% · missing: Annual results history (3+ years), Capex / investment plans, Auditor details, Recent rating review (last 15 months)

Indicative assessment from public data using the published methodology factors; not a credit rating.

Borrowing & funding lifecycle

⬇ PDF report ⬇ Excel

Can it borrow more?Further bank funding difficult Next rating action stable or better: 34% (Downgrade likely) · ML model on 6893 rating histories, AUC 0.653

Rated limits—

Not yet allocated—

Extra debt within 2.5× EBITDA—

Interest coverage—

Limit utilisation—

Open bank charges0 · —

Credit outlook model: 34% chance the next rating action is stable or better

Rated limits by facility

Timeline

04 Apr 2018 CARE other: — CARE rationale

03 Feb 2017 CARE reaffirmed: BB (Stable)Rated limits ₹31.94 cr CARE rationale

20 Oct 2015 CARE other: — CARE rationale

27 Aug 2014 CARE assigned: BB-Rated limits ₹584 cr CARE rationale

Lender names, bank charges and audited borrowings are part of Premium.

Built from MCA charges, ICRA/CARE rating reports and audited accounts. The borrowing view is an estimate, not a lender's credit decision.

Registered office and contact

Registered officeA/410 KAILASH COMPLEX VIKHROLI POWAI, LINK ROAD, PARK SITE, VIKHROLI (W)., MUMBAI, 400079

GSTIN—

Email—

Website—

Members / shareholders—

Directors and key people

Directors are read from the MGT-7 annual return and AOC-4 signatories.

Charges (secured borrowings)

0 registered charges. Lenders, amounts and dates are part of the premium plan.

Statutory auditors

Auditors are read from the AOC-4 auditor's report section.

Business activities and related parties

Principal business activities and related-party transactions are read from MGT-7 and AOC-4 filings.

Filings

No filings on record yet.